PastIn Person

Pharma and Biotech Patent Litigation Conference

by Kisaco Research

The Pharma and Biotech Patent Litigation Conference is a premier European forum dedicated to life sciences intellectual property (IP) professionals. Organized by Kisaco Research, this event is scheduled to take place from January 19 to 21, 2026, at the Beurs van Berlage in Amsterdam, Netherlands. It serves as a platform for IP counsel and litigators to benchmark enforcement strategies, navigate evolving Unified Patent Court (UPC) case law, and prepare for upcoming biosimilar and generic challenges.

The conference agenda focuses on critical issues defining market exclusivity and driving litigation across Europe. Key topics include preliminary injunctions, UPC procedures and case law, Supplementary Protection Certificates (SPCs), Bolar exemptions, second medical use claims, and biosimilar launch strategies. The program aims to equip attendees with the knowledge to defend exclusivity, manage parallel litigation across jurisdictions, and adapt to the unified enforcement landscape emerging under the UPC.

Attendees can expect a structured 1-2-1 meeting program, shared networking spaces, and curated receptions, facilitating targeted meetings with key clients, prospects, or peers. This format ensures that law firms, service providers, and corporate legal teams maximize the value of their attendance through meaningful, business-driven interactions. The event also features sessions with UPC judges, regulatory experts, and litigation funders who will share practical insights on new procedural and evidentiary frameworks shaping outcomes across Europe.

This conference is ideal for life sciences companies, including pharmaceutical innovators, biotechs, generics, and biosimilar developers, as well as private practice litigators. Attendees will benefit from benchmarking litigation strategies, learning directly from UPC decision-makers, exchanging insights with industry peers, and preparing for future regulatory and market developments that directly impact exclusivity and portfolio value.

Speakers(109)

Agathe Michel de Cazotte

Partner at Carpmaels and Ransford

Agathe Michel de Cazotte is a Partner at Carpmaels and Ransford, specializing in patent law.

Alexander de Leeuw

Partner at Powell Gilbert

Alexander de Leeuw serves as a Partner at Powell Gilbert, focusing on intellectual property litigation.

Alison Kessler

Vice President Corporate Legal Corporate and IP at Solid Biosciences

Alison Kessler serves as Vice President of Corporate Legal and IP at Solid Biosciences, overseeing the company's legal and intellectual property affairs.

Andrea Tiglio

Assistant General Counsel at Jazz Pharma

Andrea Tiglio serves as Assistant General Counsel at Jazz Pharma, managing the company's legal matters.

Andrew Hutchinson

Partner at Simmons and Simmons

Andrew Hutchinson is a Partner at Simmons and Simmons, specializing in patent litigation.

András Kupecz

Honourable Judge - Local Division Munich - UPC

András Kupecz is a judge at the Unified Patent Court's Local Division in Munich, adjudicating patent cases.

Arvid Van Oorschot

Partner at Vondst

Arvid Van Oorschot serves as a Partner at Vondst, focusing on intellectual property law.

Aude Veinante

Partner at Lavoix

Aude Veinante is a Partner at Lavoix, specializing in patent law.

Beat Weibel

Chief IP Counsel at Siemens

Beat Weibel serves as Chief IP Counsel at Siemens, overseeing the company's intellectual property strategy.

Beatriz Díaz de Escauriaza

Head of IP Legal at Insud Pharma

Beatriz Díaz de Escauriaza is the Head of IP Legal at Insud Pharma, managing the company's intellectual property matters.

Event Details

Date
January 19-21, 2026
3 days
Location
🇳🇱 Amsterdam, Netherlands
Beurs van Berlage
Pricing
Free Registration
Audience
Life sciences IP professionals, including pharmaceutical innovators, biotechs, generics, biosimilar developers, and private practice litigators.
Attendees
Approximately 600 attendees, with a 45% in-house counsel ratio.